ICP-192

· Beijing InnoCare Pharma Tech Co., Ltd.

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for ICP-192, covering 2022-07-06 to 2024-02-26. Get the full timeline:

Most recent: Clinical Trial Update: An Efficacy and Safety Study of ICP-192 in Subjects With Bladder Urothelial Cancer [Phase 2]